Rankings
▼
Calendar
RVMD Q1 2021 Earnings — Revolution Medicines, Inc. Revenue & Financial Results | Market Cap Arena
RVMD
Revolution Medicines, Inc.
$20B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$10M
-12.3% YoY
Gross Profit
$10M
100.0% margin
Operating Income
-$37M
-369.1% margin
Net Income
-$37M
-367.0% margin
EPS (Diluted)
$-0.53
QoQ Revenue Growth
+15.8%
Cash Flow
Operating Cash Flow
-$37M
Free Cash Flow
-$41M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$812M
Total Liabilities
$89M
Stockholders' Equity
$723M
Cash & Equivalents
$352M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$10M
$12M
-12.3%
Gross Profit
$10M
$12M
-12.3%
Operating Income
-$37M
-$21M
-77.4%
Net Income
-$37M
-$20M
-90.5%
Revenue Segments
Collaboration Revenue
$10M
100%
← FY 2021
All Quarters
Q2 2021 →